GEODE CAPITAL MANAGEMENT, LLC - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 38 filers reported holding SCPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,644,586
-19.8%
511,821
+14.8%
0.00%
-100.0%
Q2 2023$4,541,825
+192.1%
445,714
+160.0%
0.00%
Q1 2023$1,554,997
+223963.0%
171,444
+76.9%
0.00%
Q4 2022$694
-99.9%
96,921
+13.8%
0.00%
Q3 2022$555,000
+46.8%
85,185
+8.4%
0.00%
Q2 2022$378,000
-3.8%
78,574
+13.5%
0.00%
Q1 2022$393,000
+10.1%
69,252
-2.7%
0.00%
Q4 2021$357,000
-24.5%
71,209
-0.0%
0.00%
Q3 2021$473,000
+16.5%
71,223
+7.1%
0.00%
Q2 2021$406,000
-37.7%
66,475
-32.2%
0.00%
Q1 2021$652,000
+34.7%
98,080
+7.2%
0.00%
Q4 2020$484,000
-23.8%
91,520
+7.4%
0.00%
Q3 2020$635,000
+14.8%
85,247
+13.3%
0.00%
Q2 2020$553,000
+141.5%
75,252
+142.5%
0.00%
Q1 2020$229,000
-34.6%
31,028
-50.0%
0.00%
Q4 2019$350,000
+81.3%
62,056
+89.9%
0.00%
Q3 2019$193,000
+85.6%
32,6830.0%0.00%
Q2 2019$104,000
-37.0%
32,683
-40.6%
0.00%
Q1 2019$165,000
-57.7%
55,043
-47.0%
0.00%
Q4 2018$390,000
+32.2%
103,840
+106.5%
0.00%
Q3 2018$295,000
+11.7%
50,285
+7.4%
0.00%
Q2 2018$264,000
-47.3%
46,801
+15.7%
0.00%
Q1 2018$501,00040,4480.00%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 3,561,474$17,166,0004.25%
AIGH Capital Management LLC 1,346,724$6,491,0001.71%
Worth Venture Partners, LLC 335,985$1,784,0001.05%
Ikarian Capital, LLC 884,008$4,261,0000.78%
Orbimed Advisors 4,797,148$23,122,0000.42%
ARMISTICE CAPITAL, LLC 2,700,000$13,014,0000.23%
Sandy Cove Advisors, LLC 10,592$51,0000.05%
Belvedere Trading LLC 239,219$1,270,0000.04%
IPG Investment Advisors LLC 14,300$69,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,200$637,0000.02%
View complete list of SCPHARMACEUTICALS INC shareholders